|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer Statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim JS, Amorino GP, Pyo H, Cao Q, Price JO
and Choy H: The novel taxane analogs, BMS-184476 and BMS-188797,
potentiate the effects of radiation therapy in vitro and in vivo
against human lung cancer cells. Int J Radiat Oncol Biol Phys.
51:525–534. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palayoor ST, Bump EA, Calderwood SK,
Bartol S and Coleman CN: Combined antitumor effect of radiation and
ibuprofen in human prostate carcinoma cells. Clin Cancer Res.
4:763–771. 1998.PubMed/NCBI
|
|
4
|
Dicker AP, Williams TL and Grant DS:
Targeting angiogenic processes by combination rofecoxib and
ionizing radiation. Am J Clin Oncol. 24:438–442. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim KY, Seol JY, Jeon GA and Nam MJ: The
combined treatment of aspirin and radiation induces apoptosis by
the regulation of bcl-2 and caspase-3 in human cervical cancer
cells. Cancer Lett. 189:157–166. 2003. View Article : Google Scholar
|
|
6
|
Zhu AX and Willett CG: Chemotherapeutic
and biologic agents as radiosensitizers in rectal cancer. Semin
Radiat Oncol. 13:454–468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jones PD, de Lorimier LP, Kitchell BE and
Losonsky JM: Gemcitabine as a radiosensitizer for nonresectable
feline oral squamous cell carcinoma. J Am Anim Hosp Assoc.
39:463–467. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Begg AC, Stewart FA and Vens C: Strategies
to improve radiotherapy with targeted drugs. Nat Rev Cancer.
11:239–253. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitsudomi T, Suda K and Yatabe Y: Surgery
for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol.
10:235–244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moding EJ, Kastan MB and Kirsch DG:
Strategies for optimizing the response of cancer and normal tissues
to radiation. Nat Rev Drug Discov. 12:526–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Travis WD, Brambilla E, Noguchi M, et al:
International Association for the Study of Lung Cancer/American
Thoracic Society/European Respiratory Society: international
multi-disciplinary classification of lung adenocarcinoma: executive
summary. Proc Am Thorac Soc. 8:381–385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Swinney DC and Anthony J: How were new
medicines discovered? Nat Rev Drug Discov. 10:507–519. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rask-Andersen M, Almén MS and Schiöth HB:
Trends in the exploitation of novel drug targets. Nat Rev Drug
Discov. 10:579–590. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seelinger G, Merfort I, Wölfle U and
Schempp CM: Anti-carcinogenic effects of the flavonoid luteolin.
Molecules. 13:2628–2651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin Y, Shi R, Wang X and Shen HM:
Luteolin, a flavonoid with potential for cancer prevention and
therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Albert JM, Cao C, Kim KW, et al:
Inhibition of poly(ADP-ribose) polymerase enhances cell death and
improves tumor growth delay in irradiated lung cancer models. Clin
Cancer Res. 13:3033–3042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim EM, Yang HS, Kang SW, Ho JN, Lee SB
and Um HD: Amplification of the gamma-irradiation-induced cell
death pathway by reactive oxygen species in human U937 cells. Cell
Signal. 20:916–924. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leung HW, Kuo CL, Yang WH, Lin CH and Lee
HZ: Antioxidant enzymes activity involvement in luteolin-induced
human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol.
534:12–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rebucci M and Michiels C: Molecular
aspects of cancer cell resistance to chemotherapy. Biochem
Pharmacol. 85:1219–1226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park JK, Jung HY, Park SH, Kang SY, Yi MR,
Um HD and Hong SH: Combination of PTEN and gamma-ionizing radiation
enhances cell death and G(2)/M arrest through regulation of AKT
activity and p21 induction in non-small-cell lung cancer cells. Int
J Radiat Oncol Biol Phys. 70:1552–1560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prise KM, Schettino G, Folkard M and Held
KD: New insights on cell death from radiation exposure. Lancet
Oncol. 6:520–528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Katz D, Ito E and Liu FF: On the path to
seeking novel radiosensitizers. Int J Radiat Oncol Biol Phys.
73:988–996. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Munshi A and Ramesh R: Mitogen-activated
protein kinases and their role in radiation response. Genes Cancer.
4:401–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park JK, Chung YM, Kim BG, Yoo YA, Yang
BS, Kim JS and Yoo YD: N′-(phenyl-pyridin-2-yl-methylene)-hydrazine
carbodithioic acid methyl ester enhances radiation-induced cell
death by targeting Bcl-2 against human lung carcinoma cells. Mol
Cancer Ther. 3:403–407. 2004.PubMed/NCBI
|
|
27
|
Caputo F, Vegliante R and Ghibelli L:
Redox modulation of the DNA damage response. Biochem Pharmacol.
84:1292–1306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park MT, Kim MJ, Kang YH, et al:
Phytosphingosine in combination with ionizing radiation enhances
apoptotic cell death in radiation-resistant cancer cells through
ROS-dependent and -independent AIF release. Blood. 105:1724–1733.
2005. View Article : Google Scholar
|
|
29
|
Lee YJ, Lee DH, Cho CK, et al: HSP25
inhibits radiation-induced apoptosis through reduction of
PKCdelta-mediated ROS production. Oncogene. 24:3715–3725. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ju W, Wang X, Shi H, Chen W, Belinsky SA
and Lin Y: A critical role of luteolin-induced reactive oxygen
species in blockage of tumor necrosis factor-activated nuclear
factor-kappaB pathway and sensitization of apoptosis in lung cancer
cells. Mol Pharmacol. 71:1381–1388. 2007. View Article : Google Scholar : PubMed/NCBI
|
